Skip to main content
logo
Bio Medica Laboratories Limited (NSE:BMLL)
India flag India · Delayed Price · Currency is INR
141.45
+2.75 (1.98%)
At close: Jul 27, 2026

Bio Medica Laboratories Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
117.8197.9526.313.6-
Depreciation & Amortization
11.6310.0511.14.97-
Loss (Gain) From Sale of Assets
0.18----
Other Operating Activities
25.3832.928.847.76-
Change in Accounts Receivable
-65.23-17.6417.3713.74-
Change in Inventory
-179.04-107.71-34.65-15.74-
Change in Accounts Payable
-0.5122.53-26.3811.82-
Change in Other Net Operating Assets
29.44-74.82-10.46-19.63-
Operating Cash Flow
-60.35-36.72-7.886.52-
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
--0.19-15.26-17.1-
Sale of Property, Plant & Equipment
7.020.46---
Sale (Purchase) of Intangibles
-28.12----
Other Investing Activities
-3.121.882.76-
Investing Cash Flow
-21.13.39-13.38-14.34-

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
20.0673---
Long-Term Debt Issued
84.85-30.955.51-
Total Debt Issued
104.917330.955.51-
Short-Term Debt Repaid
--17.75---
Long-Term Debt Repaid
--10.01---
Total Debt Repaid
--27.76---
Net Debt Issued (Repaid)
104.9145.2430.955.51-
Other Financing Activities
-22.56-11.95-9.66-7.74-
Financing Cash Flow
82.3533.2921.29-2.24-

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Miscellaneous Cash Flow Adjustments
-0.05---0.01-
Net Cash Flow
0.85-0.040.04-10.07-

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-60.35-36.91-23.13-10.58-
Free Cash Flow Growth
-----
Free Cash Flow Margin
-14.00%-9.66%-15.17%-6.52%-
Free Cash Flow Per Share
-6.63-4.02-2.52-1.15-
Levered Free Cash Flow
-129.63-64.17-13.730.13-
Unlevered Free Cash Flow
-115.53-55.87-7.864.69-

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
-11.959.667.74-
Cash Income Tax Paid
-12.48---
Change in Working Capital
-215.34-177.64-54.13-9.81-